Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 205

1.

Screening, diagnosis and treatment of iron deficiency in chronic heart failure: putting the 2016 European Society of Cardiology heart failure guidelines into clinical practice.

McDonagh T, Damy T, Doehner W, Lam CSP, Sindone A, van der Meer P, Cohen-Solal A, Kindermann I, Manito N, Pfister O, Pohjantähti-Maaroos H, Taylor J, Comin-Colet J.

Eur J Heart Fail. 2018 Oct 12. doi: 10.1002/ejhf.1305. [Epub ahead of print] Review.

PMID:
30311713
2.

Comparison of the Diagnostic Accuracy of Plasma N-Terminal Pro-Brain Natriuretic Peptide in Patients <80 to those >80 Years of Age with Heart Failure.

Draper J, Webb J, Jackson T, Jones H, Rinaldi CA, Schiff R, McDonagh T, Razavi R, S Carr-White G.

Am J Cardiol. 2018 Sep 13. pii: S0002-9149(18)31765-X. doi: 10.1016/j.amjcard.2018.09.004. [Epub ahead of print]

PMID:
30309625
3.

Mortality after admission for heart failure in the UK compared with Japan.

Nagai T, Sundaram V, Rothnie K, Quint JK, Shoaib A, Shiraishi Y, Kohsaka S, Piper S, McDonagh TA, Hardman SMC, Goda A, Mizuno A, Kohno T, Rigby AS, Yoshikawa T, Clark AL, Anzai T, Cleland JGF.

Open Heart. 2018 Sep 11;5(2):e000811. doi: 10.1136/openhrt-2018-000811. eCollection 2018.

4.

Is heart failure with mid range ejection fraction (HFmrEF) a distinct clinical entity or an overlap group?

Webb J, Draper J, Fovargue L, Sieniewicz B, Gould J, Claridge S, Barton C, Smith S, Tondel K, Rajani R, Kapetanakis S, Rinaldi CA, McDonagh TA, Razavi R, Carr-White G.

Int J Cardiol Heart Vasc. 2018 Sep 6;21:1-6. doi: 10.1016/j.ijcha.2018.06.001. eCollection 2018 Dec.

5.

B-type natriuretic peptide-guided therapy for heart failure (HF): a systematic review and meta-analysis of individual participant data (IPD) and aggregate data.

Pufulete M, Maishman R, Dabner L, Higgins JPT, Rogers CA, Dayer M, MacLeod J, Purdy S, Hollingworth W, Schou M, Anguita-Sanchez M, Karlström P, Shochat MK, McDonagh T, Nightingale AK, Reeves BC.

Syst Rev. 2018 Jul 31;7(1):112. doi: 10.1186/s13643-018-0776-8.

6.

Percutaneous Revascularization for Ischemic Ventricular Dysfunction: Rationale and Design of the REVIVED-BCIS2 Trial: Percutaneous Coronary Intervention for Ischemic Cardiomyopathy.

Perera D, Clayton T, Petrie MC, Greenwood JP, O'Kane PD, Evans R, Sculpher M, Mcdonagh T, Gershlick A, de Belder M, Redwood S, Carr-White G, Marber M; REVIVED investigators.

JACC Heart Fail. 2018 Jun;6(6):517-526. doi: 10.1016/j.jchf.2018.01.024.

PMID:
29852933
7.

Validation of U.S. mortality prediction models for hospitalized heart failure in the United Kingdom and Japan.

Nagai T, Sundaram V, Shoaib A, Shiraishi Y, Kohsaka S, Rothnie KJ, Piper S, McDonagh TA, Hardman SMC, Goda A, Mizuno A, Sawano M, Rigby AS, Quint JK, Yoshikawa T, Clark AL, Anzai T, Cleland JGF.

Eur J Heart Fail. 2018 Aug;20(8):1179-1190. doi: 10.1002/ejhf.1210. Epub 2018 May 30.

PMID:
29846026
8.

Advanced heart failure: a position statement of the Heart Failure Association of the European Society of Cardiology.

Crespo-Leiro MG, Metra M, Lund LH, Milicic D, Costanzo MR, Filippatos G, Gustafsson F, Tsui S, Barge-Caballero E, De Jonge N, Frigerio M, Hamdan R, Hasin T, Hülsmann M, Nalbantgil S, Potena L, Bauersachs J, Gkouziouta A, Ruhparwar A, Ristic AD, Straburzynska-Migaj E, McDonagh T, Seferovic P, Ruschitzka F.

Eur J Heart Fail. 2018 May 27. doi: 10.1002/ejhf.1236. [Epub ahead of print]

PMID:
29806100
9.

Youth Responses to School Shootings: a Review.

Travers Á, McDonagh T, Elklit A.

Curr Psychiatry Rep. 2018 May 19;20(6):47. doi: 10.1007/s11920-018-0903-1. Review.

PMID:
29779059
10.

A Novel gp41-Binding Adnectin with Potent Anti-HIV Activity Is Highly Synergistic when Linked to a CD4-Binding Adnectin.

Wensel D, Sun Y, Davis J, Li Z, Zhang S, McDonagh T, Fabrizio D, Cockett M, Krystal M.

J Virol. 2018 May 9. pii: JVI.00421-18. doi: 10.1128/JVI.00421-18. [Epub ahead of print]

PMID:
29743355
11.

Questions and Answers on Diagnosis and Management of Patients with Peripheral Arterial Diseases: A Companion Document of the 2017 ESC Guidelines for the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS).

Aboyans V, Björck M, Brodmann M, Collet JP, Czerny M, De Carlo M, Naylor AR, Roffi M, Tendera M, Vlachopoulos C, Ricco JB, Document Reviewers, Widimsky P, Kolh P, Dick F, de Ceniga MV, Piepoli MF, Sievert H, Sulzenko J, Esc Committee For Practice Guidelines Cpg, Windecker S, Aboyans V, Agewall S, Barbato E, Bueno H, Coca A, Collet JP, Coman IM, Dean V, Delgado V, Fitzsimons D, Gaemperli O, Hindricks G, Iung B, Jüni P, Katus HA, Knuuti J, Lancellotti P, Leclercq C, McDonagh T, Piepoli MF, Ponikowski P, Richter DJ, Roffi M, Shlyakhto E, Simpson IA, Zamorano JL.

Eur J Vasc Endovasc Surg. 2018 Apr;55(4):457-464. doi: 10.1016/j.ejvs.2017.08.014. Epub 2018 Apr 6. No abstract available.

PMID:
29628287
12.

Type 2 diabetes mellitus and heart failure: a position statement from the Heart Failure Association of the European Society of Cardiology.

Seferović PM, Petrie MC, Filippatos GS, Anker SD, Rosano G, Bauersachs J, Paulus WJ, Komajda M, Cosentino F, de Boer RA, Farmakis D, Doehner W, Lambrinou E, Lopatin Y, Piepoli MF, Theodorakis MJ, Wiggers H, Lekakis J, Mebazaa A, Mamas MA, Tschöpe C, Hoes AW, Seferović JP, Logue J, McDonagh T, Riley JP, Milinković I, Polovina M, van Veldhuisen DJ, Lainscak M, Maggioni AP, Ruschitzka F, McMurray JJV.

Eur J Heart Fail. 2018 May;20(5):853-872. doi: 10.1002/ejhf.1170. Epub 2018 Mar 8. Review.

13.

A cost effectiveness study establishing the impact and accuracy of implementing the NICE guidelines lowering plasma NTproBNP threshold in patients with clinically suspected heart failure at our institution.

Webb J, Draper J, Rua T, Yiu Y, Piper S, Teall T, Fovargue L, Bolca E, Jackson T, Claridge S, Sieniewicz B, Porter B, McDiarmid A, Rajani R, Kapetanakis S, Rinaldi CA, Razavi R, McDonagh TA, Carr-White G.

Int J Cardiol. 2018 Apr 15;257:131-136. doi: 10.1016/j.ijcard.2017.10.126.

PMID:
29506684
14.

In-hospital worsening heart failure: a clinically relevant endpoint?

Clark AL, Cherif M, McDonagh TA, Squire IB.

ESC Heart Fail. 2018 Feb;5(1):9-18. doi: 10.1002/ehf2.12195. Epub 2017 Jul 18. Review.

15.

Training the next generation of psychotraumatologists: COllaborative Network for Training and EXcellence in psychoTraumatology (CONTEXT).

Vallières F, Hyland P, Murphy J, Hansen M, Shevlin M, Elklit A, Ceannt R, Armour C, Wiedemann N, Munk M, Dinesen C, O'Hare G, Cunningham T, Askerod D, Spitz P, Blackwell N, McCarthy A, O'Dowd L, Scott S, Reid T, Mokake A, Halpin R, Perera C, Gleeson C, Frost R, Flanagan N, Aldamman K, Tamrakar T, Louison Vang M, Sherwood L, Travers Á, Haahr-Pedersen I, Walshe C, McDonagh T, Bramsen RH.

Eur J Psychotraumatol. 2018 Jan 16;9(1):1421001. doi: 10.1080/20008198.2017.1421001. eCollection 2018.

16.

Daily home BNP monitoring in heart failure for prediction of impending clinical deterioration: results from the HOME HF study.

McDonald K, Troughton R, Dahlström U, Dargie H, Krum H, van der Meer P, McDonagh T, Atherton JJ, Kupfer K, San George RC, Richards M, Doughty R.

Eur J Heart Fail. 2018 Mar;20(3):474-480. doi: 10.1002/ejhf.1053. Epub 2018 Jan 4.

PMID:
29314505
17.

Corrigendum to '2017 ESC/EACTS Guidelines for the management of valvular heart disease' [Eur J Cardiothorac Surg 2017;52:616-664].

Falk V, Baumgartner H, Bax JJ, De Bonis M, Hamm C, Holm PJ, Iung B, Lancellotti P, Lansac E, Muñoz DR, Rosenhek R, Sjögren J, Tornos Mas P, Vahanian A, Walther T, Wendler O, Windecker S, Zamorano JL, Roffi M, Alfieri O, Agewall S, Ahlsson A, Barbato E, Bueno H, Collet JP, Coman IM, Czerny M, Delgado V, Fitzsimons D, Folliguet T, Gaemperli O, Habib G, Harringer W, Haude M, Hindricks G, Katus HA, Knuuti J, Kolh P, Leclercq C, McDonagh TA, Piepoli MF, Pierard LA, Ponikowski P, Rosano GMC, Ruschitzka F, Shlyakhto E, Simpson IA, Sousa-Uva M, Stepinska J, Tarantini G, Tchétché D, Aboyans V.

Eur J Cardiothorac Surg. 2017 Oct 1;52(4):832. doi: 10.1093/ejcts/ezx363. No abstract available.

18.

Biological Phenotypes of Heart Failure With Preserved Ejection Fraction.

Lewis GA, Schelbert EB, Williams SG, Cunnington C, Ahmed F, McDonagh TA, Miller CA.

J Am Coll Cardiol. 2017 Oct 24;70(17):2186-2200. doi: 10.1016/j.jacc.2017.09.006. Review.

19.

Hearts and Minds: Real-Life Cardiotoxicity With Clozapine in Psychosis.

Joy G, Whiskey E, Bolstridge M, Porras-Segovia A, McDonagh TA, Plymen CM, Shergill SS.

J Clin Psychopharmacol. 2017 Dec;37(6):708-712. doi: 10.1097/JCP.0000000000000792.

PMID:
29049078
20.

Drug treatment effects on outcomes in heart failure with preserved ejection fraction: a systematic review and meta-analysis.

Zheng SL, Chan FT, Nabeebaccus AA, Shah AM, McDonagh T, Okonko DO, Ayis S.

Heart. 2018 Mar;104(5):407-415. doi: 10.1136/heartjnl-2017-311652. Epub 2017 Aug 5.

21.

Effectiveness and cost-effectiveness of serum B-type natriuretic peptide testing and monitoring in patients with heart failure in primary and secondary care: an evidence synthesis, cohort study and cost-effectiveness model.

Pufulete M, Maishman R, Dabner L, Mohiuddin S, Hollingworth W, Rogers CA, Higgins J, Dayer M, Macleod J, Purdy S, McDonagh T, Nightingale A, Williams R, Reeves BC.

Health Technol Assess. 2017 Aug;21(40):1-150. doi: 10.3310/hta21400.

22.

Assessing infant and maternal readiness for newborn discharge.

Jing L, Bethancourt CN, McDonagh T.

Curr Opin Pediatr. 2017 Oct;29(5):598-605. doi: 10.1097/MOP.0000000000000526. Review.

PMID:
28731912
23.

Discovery and Characterization of a Novel CD4-Binding Adnectin with Potent Anti-HIV Activity.

Wensel D, Sun Y, Li Z, Zhang S, Picarillo C, McDonagh T, Fabrizio D, Cockett M, Krystal M, Davis J.

Antimicrob Agents Chemother. 2017 Jul 25;61(8). pii: e00508-17. doi: 10.1128/AAC.00508-17. Print 2017 Aug.

24.

Dynamic transcatheter mitral valve repair: a new concept to treat functional mitral regurgitation using an adjustable spacer.

Silaschi M, Nicou N, Eskandari M, Aldalati O, Seguin C, Piemonte T, McDonagh T, Dworakowski R, Byrne J, MacCarthy P, Monaghan M, Wendler O.

EuroIntervention. 2017 Jun 20;13(3):280-283. doi: 10.4244/EIJ-D-16-00970.

25.

Identifying patients with less potential to benefit from implantable cardioverter-defibrillator therapy: comparison of the performance of four risk scoring systems.

Kaura A, Sunderland N, Kamdar R, Petzer E, McDonagh T, Murgatroyd F, Dhillon P, Scott P.

J Interv Card Electrophysiol. 2017 Aug;49(2):181-189. doi: 10.1007/s10840-017-0243-9. Epub 2017 Apr 6.

26.

MICE or NICE? An economic evaluation of clinical decision rules in the diagnosis of heart failure in primary care.

Monahan M, Barton P, Taylor CJ, Roalfe AK, Hobbs FDR; REFER investigators, Cowie M, Davis R, Deeks J, Mant J, McCahon D, McDonagh T, Sutton G, Tait L.

Int J Cardiol. 2017 Aug 15;241:255-261. doi: 10.1016/j.ijcard.2017.02.149. Epub 2017 Mar 2.

27.

Model-based cost-effectiveness analysis of B-type natriuretic peptide-guided care in patients with heart failure.

Mohiuddin S, Reeves B, Pufulete M, Maishman R, Dayer M, Macleod J, McDonagh T, Purdy S, Rogers C, Hollingworth W.

BMJ Open. 2016 Dec 28;6(12):e014010. doi: 10.1136/bmjopen-2016-014010.

28.

Primary care REFerral for EchocaRdiogram (REFER) in heart failure: a diagnostic accuracy study.

Taylor CJ, Roalfe AK, Iles R, Hobbs FR; REFER investigators, Barton P, Deeks J, McCahon D, Cowie MR, Sutton G, Davis RC, Mant J, McDonagh T, Tait L.

Br J Gen Pract. 2017 Feb;67(655):e94-e102. doi: 10.3399/bjgp16X688393. Epub 2016 Dec 5.

29.

Referral for Specialist Follow-up and Its Association With Post-discharge Mortality Among Patients With Systolic Heart Failure (from the National Heart Failure Audit for England and Wales).

Emdin CA, Hsiao AJ, Kiran A, Conrad N, Salimi-Khorshidi G, Woodward M, Anderson SG, Mohseni H, McMurray JJ, Cleland JG, Dargie H, Hardman S, McDonagh T, Rahimi K.

Am J Cardiol. 2017 Feb 1;119(3):440-444. doi: 10.1016/j.amjcard.2016.10.021. Epub 2016 Nov 1.

30.

The healthcare costs of heart failure during the last five years of life: A retrospective cohort study.

Hollingworth W, Biswas M, Maishman RL, Dayer MJ, McDonagh T, Purdy S, Reeves BC, Rogers CA, Williams R, Pufulete M.

Int J Cardiol. 2016 Dec 1;224:132-138. doi: 10.1016/j.ijcard.2016.09.021. Epub 2016 Sep 15.

PMID:
27648982
31.

Variation in hospital performance for heart failure management in the National Heart Failure Audit for England and Wales.

Emdin CA, Conrad N, Kiran A, Salimi-Khorshidi G, Woodward M, Anderson SG, Mohseni H, Dargie HJ, Hardman SM, McDonagh T, McMurray JJ, Cleland JG, Rahimi K.

Heart. 2017 Jan 1;103(1):55-62. doi: 10.1136/heartjnl-2016-309706. Epub 2016 Aug 16.

32.

Biomarkers in Persistent AF and Heart Failure: Impact of Catheter Ablation Compared with Rate Control.

Jones DG, Haldar SK, Donovan J, McDonagh TA, Sharma R, Hussain W, Markides V, Wong T.

Pacing Clin Electrophysiol. 2016 Sep;39(9):926-34. doi: 10.1111/pace.12919. Epub 2016 Aug 17.

33.

Ironing out iron deficiency in heart failure.

McDonagh TA.

Eur J Heart Fail. 2016 Jul;18(7):796-7. doi: 10.1002/ejhf.597. Epub 2016 Jul 13. No abstract available.

34.

Erratum to "Traditional and new composite endpoints in heart failure clinical trials: facilitating comprehensive efficacy assessments and improving trial efficiency" [Eur J Heart Fail 2016;18:482-489].

Anker SD, Schroeder S, Atar D, Bax JJ, Ceconi C, Cowie MR, Crisp A, Dominjon F, Ford I, Ghofrani HA, Gropper S, Hindricks G, Hlatky MA, Holcomb R, Honarpour N, Jukema JW, Kim AM, Kunz M, Lefkowitz M, Floch CL, Landmesser U, McDonagh TA, McMurray JJ, Merkely B, Packer M, Prasad K, Revkin J, Rosano GM, Somaratne R, Stough WG, Voors AA, Ruschitzka F.

Eur J Heart Fail. 2016 Jun;18(6):727. doi: 10.1002/ejhf.591. No abstract available.

35.

Heart Failure Association of the European Society of Cardiology heart failure nurse curriculum.

Riley JP, Astin F, Crespo-Leiro MG, Deaton CM, Kienhorst J, Lambrinou E, McDonagh TA, Rushton CA, Stromberg A, Filippatos G, Anker SD.

Eur J Heart Fail. 2016 Jul;18(7):736-43. doi: 10.1002/ejhf.568. Epub 2016 May 25.

36.

Biologic Variability of Soluble ST2 in Patients With Stable Chronic Heart Failure and Implications for Monitoring.

Piper S, deCourcey J, Sherwood R, Amin-Youssef G, McDonagh T.

Am J Cardiol. 2016 Jul 1;118(1):95-8. doi: 10.1016/j.amjcard.2016.04.017. Epub 2016 Apr 21.

PMID:
27189812
37.

EACVI appropriateness criteria for the use of cardiovascular imaging in heart failure derived from European National Imaging Societies voting.

Garbi M, Edvardsen T, Bax J, Petersen SE, McDonagh T, Filippatos G, Lancellotti P; Reviewer panel:.

Eur Heart J Cardiovasc Imaging. 2016 Jul;17(7):711-21. doi: 10.1093/ehjci/jew081. Epub 2016 Apr 29. Review.

38.

Traditional and new composite endpoints in heart failure clinical trials: facilitating comprehensive efficacy assessments and improving trial efficiency.

Anker SD, Schroeder S, Atar D, Bax JJ, Ceconi C, Cowie MR, Crisp A, Dominjon F, Ford I, Ghofrani HA, Gropper S, Hindricks G, Hlatky MA, Holcomb R, Honarpour N, Jukema JW, Kim AM, Kunz M, Lefkowitz M, Le Floch C, Landmesser U, McDonagh TA, McMurray JJ, Merkely B, Packer M, Prasad K, Revkin J, Rosano GM, Somaratne R, Stough WG, Voors AA, Ruschitzka F.

Eur J Heart Fail. 2016 May;18(5):482-9. doi: 10.1002/ejhf.516. Epub 2016 Apr 12. Review. Erratum in: Eur J Heart Fail. 2016 Jun;18(6):727.

39.

Heart failure specialization in Europe.

Westenbrink BD, Brugts JJ, McDonagh TA, Filippatos G, Ruschitzka F, van Laake LW.

Eur J Heart Fail. 2016 Apr;18(4):347-9. doi: 10.1002/ejhf.506. Epub 2016 Apr 12. No abstract available.

40.

2015 ESC/ERS Guidelines for the Diagnosis and Treatment of Pulmonary Hypertension.

Galiè N, Humbert M, Vachiery JL, Gibbs S, Lang I, Torbicki A, Simonneau G, Peacock A, Vonk Noordegraaf A, Beghetti M, Ghofrani A, Gomez Sanchez MA, Hansmann G, Klepetko W, Lancellotti P, Matucci M, McDonagh T, Pierard LA, Trindade PT, Zompatori M, Hoeper M.

Rev Esp Cardiol (Engl Ed). 2016 Feb;69(2):177. doi: 10.1016/j.rec.2016.01.002. No abstract available.

PMID:
26837729
41.

Serial galectin-3 for the monitoring of optimally treated stable chronic heart failure: A pilot study.

Piper SE, de Courcey J, Sherwood RA, Amin-Youssef GF, McDonagh TA.

Int J Cardiol. 2016 Mar 15;207:279-81. doi: 10.1016/j.ijcard.2016.01.179. Epub 2016 Jan 13. No abstract available.

PMID:
26808993
42.

Treatment of heart failure in adult congenital heart disease: a position paper of the Working Group of Grown-Up Congenital Heart Disease and the Heart Failure Association of the European Society of Cardiology.

Budts W, Roos-Hesselink J, Rädle-Hurst T, Eicken A, McDonagh TA, Lambrinou E, Crespo-Leiro MG, Walker F, Frogoudaki AA.

Eur Heart J. 2016 May 7;37(18):1419-27. doi: 10.1093/eurheartj/ehv741. Epub 2016 Jan 18. Review. No abstract available.

43.

[2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension].

Galiè N, Humbert M, Vachiery JL, Gibbs S, Lang I, Torbicki A, Simonneau G, Peacock A, Vonk Noordegraaf A, Beghetti M, Ghofrani A, Sanchez MA, Hansmann G, Klepetko W, Lancellotti P, Matucci M, McDonagh T, Pierard LA, Trindade PT, Zompatori M, Hoeper M.

Kardiol Pol. 2015;73(12):1127-206. doi: 10.5603/KP.2015.0242. Polish. No abstract available.

44.

Correction: Sirt1 Regulates Insulin Secretion by Repressing UCP2 in Pancreatic β Cells.

Bordone L, Motta MC, Picard F, Robinson A, Jhala US, Apfeld J, McDonagh T, Lemieux M, McBurney M, Szilvasi A, Easlon EJ, Lin SJ, Guarente L.

PLoS Biol. 2015 Dec 29;13(12):e1002346. doi: 10.1371/journal.pbio.1002346. eCollection 2015 Dec. No abstract available.

45.

2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT).

Galiè N, Humbert M, Vachiery JL, Gibbs S, Lang I, Torbicki A, Simonneau G, Peacock A, Vonk Noordegraaf A, Beghetti M, Ghofrani A, Gomez Sanchez MA, Hansmann G, Klepetko W, Lancellotti P, Matucci M, McDonagh T, Pierard LA, Trindade PT, Zompatori M, Hoeper M; ESC Scientific Document Group .

Eur Heart J. 2016 Jan 1;37(1):67-119. doi: 10.1093/eurheartj/ehv317. Epub 2015 Aug 29. No abstract available.

46.

2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT).

Galiè N, Humbert M, Vachiery JL, Gibbs S, Lang I, Torbicki A, Simonneau G, Peacock A, Vonk Noordegraaf A, Beghetti M, Ghofrani A, Gomez Sanchez MA, Hansmann G, Klepetko W, Lancellotti P, Matucci M, McDonagh T, Pierard LA, Trindade PT, Zompatori M, Hoeper M.

Eur Respir J. 2015 Oct;46(4):903-75. doi: 10.1183/13993003.01032-2015. Epub 2015 Aug 29. Erratum in: Eur Respir J. 2015 Dec;46(6):1855-6.

47.

Pharmacology of smac mimetics; chemotype differentiation based on physical association with caspase regulators and cellular transport.

Talbott RL, Borzilleri RM, Chaudhry C, Fargnoli J, Shen H, Fairchild C, Barnhart B, Ortega M, McDonagh TE, Vuppugalla R, Vite GD, Hunt JT, Gottardis M, Naglich JG.

Exp Cell Res. 2015 Nov 1;338(2):251-60. doi: 10.1016/j.yexcr.2015.08.011. Epub 2015 Aug 21.

PMID:
26302264
48.

Heart failure and chemotherapeutic agents.

Piper S, McDonagh T.

Future Cardiol. 2015 Jul;11(4):453-70. doi: 10.2217/fca.15.28. Epub 2015 Aug 3. Review.

PMID:
26234158
49.

Prospective cohort study of the relationship between neuro-cognition, social cognition and violence in forensic patients with schizophrenia and schizoaffective disorder.

O'Reilly K, Donohoe G, Coyle C, O'Sullivan D, Rowe A, Losty M, McDonagh T, McGuinness L, Ennis Y, Watts E, Brennan L, Owens E, Davoren M, Mullaney R, Abidin Z, Kennedy HG.

BMC Psychiatry. 2015 Jul 10;15:155. doi: 10.1186/s12888-015-0548-0.

50.

Chemotherapy-related Cardiomyopathy.

Piper SE, McDonagh TA.

Eur Cardiol. 2015 Jul;10(1):19-24. doi: 10.15420/ecr.2015.10.01.19. Review.

Supplemental Content

Loading ...
Support Center